Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Complications of retroperitoneal lymph node dissection.

J P Donohue, R G Rowland

    The Journal of Urology
    |March 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Indications for continent diversion after cystectomy and factors affecting long-term results.

    Urologic oncology·2011
    Same author

    [Nerve sparing retroperitoneal lymphadenectomy (RLA)].

    Aktuelle Urologie·2010
    Same author

    Early growth response-1 gene: potential radiation response gene marker in prostate cancer.

    American journal of clinical oncology·2001
    Same author

    Macroscopic, microscopic and molecular observations of bladder cancer.

    The Journal of urology·2001
    Same author

    Germ cell tumor associated primitive neuroectodermal tumors.

    The Journal of urology·2001
    Same author

    Aortic replacement during post-chemotherapy retroperitoneal lymph node dissection.

    The Journal of urology·2001

    Surgical complications following retroperitoneal dissection for testis cancer are generally manageable. However, advanced disease (stage III) and extensive cytoreductive operations significantly increase operative difficulties and postoperative complications.

    Area of Science:

    • Urology
    • Surgical Oncology

    Background:

    • Retroperitoneal dissection is a key surgical procedure for testis cancer.
    • Understanding surgical morbidity is crucial for patient outcomes.

    Purpose of the Study:

    • To evaluate surgical morbidity in patients undergoing retroperitoneal dissection for testis cancer.
    • To identify factors associated with increased complications.

    Main Methods:

    • Retrospective review of 235 patients with testis cancer (stages I, II, and III) who underwent retroperitoneal dissection.
    • Analysis of early and late postoperative complications.

    Main Results:

    • Overall complication rate of 11.9% (28/235 patients) was comparable to other reports.
    • A significant increase in operative difficulties and complications was observed in advanced stage III disease (13/49 patients).

    Related Experiment Videos

  • Patients undergoing extensive primary cytoreductive operations experienced higher complication rates.

    • Conclusions:

    • Complication rates are directly related to disease extent and surgical intervention intensity.
    • Factors like increased operative time, technical demands, and patient's pre-existing conditions (e.g., post-chemotherapy status) contribute to morbidity.
    • Management strategies for patients with extensive, chemotherapy-altered testis cancer require specific consideration.